Strengths of our study include the large number of patients spanning the AD continuum, within-subject measurements of multiple CSF p-tau isoforms and their comparison to the widely used p-tau181 from Innotest and Elecsys, and the availability of Aβ and tau-PET imaging. Here, MAPT is linked to Alzheimer disease.